Epilepsy syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:166463
Who is this for?
Show terms as
27Active trials44Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Epilepsy syndrome is a broad classification term used in Orphanet (ORPHA:166463) to encompass a group of epileptic disorders defined by a cluster of clinical features including seizure types, electroencephalographic (EEG) patterns, age of onset, and associated comorbidities. Epilepsy syndromes affect the central nervous system, specifically the brain, where abnormal electrical activity leads to recurrent, unprovoked seizures. These seizures can manifest in many forms, including generalized tonic-clonic convulsions, absence seizures, focal seizures with or without impaired awareness, myoclonic jerks, and atonic episodes. Depending on the specific syndrome, patients may also experience developmental delay, intellectual disability, behavioral disturbances, and neurological regression. The clinical presentation varies widely across the many recognized epilepsy syndromes. Some syndromes, such as childhood absence epilepsy or juvenile myoclonic epilepsy, are relatively benign and respond well to antiseizure medications, while others, such as Dravet syndrome or Lennox-Gastaut syndrome, are severe epileptic encephalopathies associated with drug-resistant seizures and significant neurodevelopmental impairment. Diagnosis typically involves clinical history, EEG findings, neuroimaging, and increasingly, genetic testing, as many epilepsy syndromes have identified genetic etiologies involving ion channel genes, synaptic proteins, and other neuronal regulatory molecules. Treatment of epilepsy syndromes depends on the specific diagnosis and may include antiseizure medications (such as valproate, levetiracetam, lamotrigine, or ethosuximide), dietary therapies (such as the ketogenic diet), neurostimulation devices (vagus nerve stimulation, responsive neurostimulation), and in selected cases, epilepsy surgery. Emerging precision medicine approaches, including gene-specific therapies, are being developed for certain genetic epilepsy syndromes. Management often requires a multidisciplinary team including neurologists, geneticists, neuropsychologists, and rehabilitation specialists to address the full spectrum of clinical needs.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Dec 2026Accelerated iTBS for Depression and Suicidality

University of Iowa — NA

TrialNOT YET RECRUITING
May 2026Overnight TI in TLE

Duke University — NA

TrialNOT YET RECRUITING
Apr 2026MRI Volumetry and Diffusion Tensor Imaging in Temporal Lobe Epilepsy

Assiut University

TrialNOT YET RECRUITING
Apr 2026A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome

Hospices Civils de Lyon — NA

TrialNOT YET RECRUITING
Mar 2026COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

Yale University — PHASE3

TrialNOT YET RECRUITING
Dec 2025LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau — PHASE3

TrialRECRUITING
Aug 2025Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies

Heather Olson — PHASE1

TrialRECRUITING
Jul 2025MRgLITT for mTLE: A PROBE Trial

Beijing Tiantan Hospital — NA

TrialRECRUITING
Jun 2025Registry and Natural History of Epilepsy-Dyskinesia Syndromes

Boston Children's Hospital

TrialRECRUITING
Jun 2025Coronary and Cerebral Microvascular Dysfunction in Neurological Diseases

University Medicine Greifswald

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Epilepsy syndrome.

20 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

20 recruitingView all trials with filters →
Phase 31 trial
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Phase 3
Actively Recruiting
· Sites: Granada, Andalusia; Donostia / San Sebastian, Basque Country +3 more · Age: 4099 yrs
Phase 41 trial
Quality Improvement and Practice Based Research in Neurology Using the EMR
Phase 4
Enrolling by Invitation
· Sites: Evanston, Illinois · Age: 18100 yrs
Phase 21 trial
RNS System LGS Feasibility Study
Phase 2
Active
PI: Martha Morrell, MD (NeuroPace, Inc.) · Sites: Birmingham, Alabama; San Francisco, California +4 more · Age: 1299 yrs
N/A1 trial
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
N/A
Actively Recruiting
PI: Darius Ebrahimi-Fakhari, MD, PhD. · Sites: Boston, Massachusetts · Age: 018 yrs
Other16 trials
Idiopathic Generalized Epilepsy Syndromes
Actively Recruiting
PI: Chunhong Shen (Second Affiliated Hospital, School of Medicine, Zh) · Sites: Hangzhou, Zhejiang · Age: 440 yrs
Brain Metabolism Observed at 7 Tesla
Actively Recruiting
· Sites: Dallas, Texas · Age: 1665 yrs
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Actively Recruiting
PI: Yan He (Zhujiang Hospital) · Sites: Chaoyang, Beijing Municipality; Nanchuan, Chongqing Municipality +48 more · Age: 1875 yrs
Patterns of Neurodevelopmental Disorders
Actively Recruiting
· Sites: Phoenix, Arizona
Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome
Actively Recruiting
PI: Prof Andrew Hattersley (University of Exeter / Royal Devon University Heal) · Sites: Chicago, Illinois; Rome +2 more · Age: 250 yrs
Registry and Natural History of Epilepsy-Dyskinesia Syndromes
Actively Recruiting
· Sites: Boston, Massachusetts · Age: 030 yrs
Investigating Epilepsy: Screening and Evaluation
Actively Recruiting
PI: Yasser Tajali, M.D. (National Institute of Neurological Disorders and S) · Sites: Bethesda, Maryland · Age: 8110 yrs
High-field MR Imaging in Migraine, Visual Snow and Epilepsy
Actively Recruiting
PI: Patrick Freund, Prof. Dr. med. Dr. rer. nat. (University of Zurich) · Sites: Zurich; Zurich · Age: 1865 yrs
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
Actively Recruiting
PI: François CREMIEUX (Assistance Publique - Hôpitaux de Marseille) · Sites: Marseille · Age: 1890 yrs
Genetic Markers of Cardiovascular Disease in Epilepsy
Actively Recruiting
PI: Virend K. Somers, MD PhD (Mayo Clinic) · Sites: Rochester, Minnesota · Age: 1850 yrs
Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes
Actively Recruiting
PI: Patrick Van Bogaert, Professor (Angers University Hospital) · Sites: Angers; Strasbourg +1 more · Age: 615 yrs
MEHMO Natural History and Biomarkers
Actively Recruiting
PI: An N Dang Do, M.D. (Eunice Kennedy Shriver National Institute of Child) · Sites: Bethesda, Maryland · Age: 0100 yrs
SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom
Actively Recruiting
PI: Andreas Brunklaus, MD PhD (NHS Greater Glasgow & Clyde) · Sites: Glasgow
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Actively Recruiting
PI: Li Ma, MD, PhD (Beijing Tiantan Hospital) · Sites: Beijing, Beijing Municipality; Beijing, Beijing Municipality · Age: 1870 yrs
Quest to Analyze One Thousand Humans Meditating
Enrolling by Invitation
PI: Tobias Moeller-Bertram, MD (VitaMed Research LLC) · Sites: Palm Desert, California · Age: 2199 yrs
Surgery as a Treatment for Medically Intractable Epilepsy
Actively Recruiting
PI: Kareem A Zaghloul, M.D. (National Institute of Neurological Disorders and S) · Sites: Bethesda, Maryland · Age: 899 yrs

Specialists

Showing 25 of 44View all specialists →
DP
Darius Ebrahimi-Fakhari, MD, PhD.
Boston, Massachusetts
Specialist

Rare Disease Specialist

KM
Kelly Knupp, MD
AKRON, OH
Specialist
PI on 3 active trials
CS
Chunhong Shen
Specialist
PI on 2 active trials92 Epilepsy syndrome publications
AM
Amit Ray, MD
Kissimmee, Florida
Specialist

Rare Disease Specialist

PI on 2 active trials1 Epilepsy syndrome publication
HT
Hiroki Takano
Specialist
PI on 2 active trials17 Epilepsy syndrome publications
MM
Marc Kamin, MD
OYSTER BAY, NY
Specialist
PI on 3 active trials
BM
Beverly S Wical, MD
SAINT PAUL, MN
Specialist
PI on 2 active trials
SM
Sara K Inati, M.D.
BETHESDA, MD
Specialist
PI on 2 active trials
AP
Anna Jansen, MD, PhD
Silver Spring, Maryland
Specialist

Rare Disease Specialist

PI on 2 active trials
LM
Liankun Ren, MD
Specialist
PI on 4 active trials1 Epilepsy syndrome publication
WM
William H Theodore, M.D.
BETHESDA, MD
Specialist
PI on 5 active trials
HP
Hal Blumenfeld, MD, PhD
NEW HAVEN, CT
Specialist
PI on 2 active trials
SD
Suvasini Sharma, MD, DM
Specialist
PI on 2 active trials
VG
Victoria Guinet
Specialist
PI on 1 active trial
MH
Manisha Holmes
HAWTHORNE, NY
Specialist
PI on 1 active trial
KZ
Kareem A Zaghloul
PHILADELPHIA, PA
Specialist
PI on 1 active trial
LH
Lawrence Hirsch
Specialist
PI on 1 active trial
DP
Deb K. Pal
Specialist
PI on 1 active trial
BA
BENOILID Aurélien
Specialist
PI on 1 active trial
MD
Marie DENUELLE
Specialist
PI on 1 active trial
SJ
Seriusz Jozwiak
Specialist
PI on 1 active trial
CC
Catherine Chu
Specialist
PI on 1 active trial
MG
Muhlike Guler
Specialist
PI on 1 active trial
LL
Lieven G Lagae
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Epilepsy syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Epilepsy syndromeForum →

No community posts yet. Be the first to share your experience with Epilepsy syndrome.

Start the conversation →

Latest news about Epilepsy syndrome

Disease timeline:

New recruiting trial: A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

A new clinical trial is recruiting patients for Epilepsy syndrome

New recruiting trial: Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

A new clinical trial is recruiting patients for Epilepsy syndrome

New recruiting trial: Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy

A new clinical trial is recruiting patients for Epilepsy syndrome

New recruiting trial: SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom

A new clinical trial is recruiting patients for Epilepsy syndrome

New recruiting trial: GABA Biomarkers in Dravet Syndrome

A new clinical trial is recruiting patients for Epilepsy syndrome

New recruiting trial: Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

A new clinical trial is recruiting patients for Epilepsy syndrome

New recruiting trial: A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

A new clinical trial is recruiting patients for Epilepsy syndrome

New recruiting trial: Evaluation of the NaviFUS System in Drug Resistant Epilepsy

A new clinical trial is recruiting patients for Epilepsy syndrome

New recruiting trial: Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies

A new clinical trial is recruiting patients for Epilepsy syndrome

New recruiting trial: A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

A new clinical trial is recruiting patients for Epilepsy syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Epilepsy syndrome

What is Epilepsy syndrome?

Epilepsy syndrome is a broad classification term used in Orphanet (ORPHA:166463) to encompass a group of epileptic disorders defined by a cluster of clinical features including seizure types, electroencephalographic (EEG) patterns, age of onset, and associated comorbidities. Epilepsy syndromes affect the central nervous system, specifically the brain, where abnormal electrical activity leads to recurrent, unprovoked seizures. These seizures can manifest in many forms, including generalized tonic-clonic convulsions, absence seizures, focal seizures with or without impaired awareness, myoclonic

Are there clinical trials for Epilepsy syndrome?

Yes — 20 recruiting clinical trials are currently listed for Epilepsy syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Epilepsy syndrome?

25 specialists and care centers treating Epilepsy syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.